Contrasting Arcadia Biosciences (NASDAQ:RKDA) & Luckin Coffee (OTCMKTS:LKNCY)

Luckin Coffee (OTCMKTS:LKNCY – Get Free Report) and Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) are both consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Luckin Coffee and Arcadia Biosciences, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Luckin Coffee 0 0 1 3 3.75
Arcadia Biosciences 1 0 0 0 1.00

Luckin Coffee presently has a consensus target price of $46.87, suggesting a potential upside of 26.05%. Given Luckin Coffee’s stronger consensus rating and higher probable upside, equities analysts plainly believe Luckin Coffee is more favorable than Arcadia Biosciences.

Volatility and Risk

Luckin Coffee has a beta of -0.32, suggesting that its stock price is 132% less volatile than the S&P 500. Comparatively, Arcadia Biosciences has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500.

Valuation and Earnings

This table compares Luckin Coffee and Arcadia Biosciences”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Luckin Coffee $7.03 billion 1.52 $513.88 million $2.00 18.59
Arcadia Biosciences $4.86 million 0.09 -$2.34 million ($4.89) -0.04

Luckin Coffee has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Luckin Coffee, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

0.5% of Luckin Coffee shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 2.7% of Luckin Coffee shares are owned by company insiders. Comparatively, 4.5% of Arcadia Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Luckin Coffee and Arcadia Biosciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Luckin Coffee 7.51% 26.98% 13.10%
Arcadia Biosciences -202.09% -203.20% -90.95%

Summary

Luckin Coffee beats Arcadia Biosciences on 12 of the 15 factors compared between the two stocks.

About Luckin Coffee

(Get Free Report)

Luckin Coffee is a Chinese coffeehouse company founded in 2017. It operates a technology-driven retail business, using mobile ordering and a network of stores to serve customers through pickup and delivery. The company’s offerings include freshly brewed coffee, tea and other beverages, along with selected food items. Its menu and promotions are designed for convenient, frequent purchases through its app and other digital channels. Luckin Coffee primarily serves customers in China and has also expanded into Singapore.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc. is an agricultural biotechnology and food company focused on developing and commercializing plant-based products. The company has historically used plant breeding and biotechnology to develop crop traits, including traits intended to improve crop performance and the nutritional qualities of food. Its consumer-facing GoodWheat brand is built around wheat varieties bred for higher fiber and protein content. Products have included wheat flour, pasta and crackers, which are marketed to consumers seeking more nutritious options made with familiar grain ingredients.

Receive News & Ratings for Luckin Coffee Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luckin Coffee and related companies with MarketBeat.com's FREE daily email newsletter.